news 
A Scientific, Economic and Ethical Reflection on Women’s (Health) History
As we close the chapter on Women’s History Month, it is essential to acknowledge the significance of women’s health in society. Unfortunately, women in the United States have the lowest life expectancy at 80 years, compared to their peers in other high-income countries, and are also plagued by a higher rate of avoidable deaths. The time has come for us to refocus our attention on this critical issue.
From a scientific perspective, it is crucial that we recognize the unique challenges women face in terms of health research. Historically, women have been underrepresented in clinical trials, with stark consequences for the development of effective treatments and interventions. Prior to the National Institutes of Health Revitalization Act of 1993, women’s participation in NIH-funded clinical research was merely a recommendation, not a requirement. This glaring omission has led to a dearth of data on how women will respond to treatment options, rendering them ineffective or even harmful. To combat this issue, we must prioritize the inclusion of women in trials, ensuring that therapeutic interventions are grounded in an accurate representation of the population.
Furthermore, it is essential to acknowledge the significant economic burden that menopausal symptoms impose on working women. Recent data reveals that 75.2% and 59.6% of women aged 45-54 and 55-64, respectively, struggle with these debilitating symptoms. These biological changes have a direct impact on lost work productivity, resulting in an astonishing $1.8 billion annually. This staggering figure does not account for the additional costs associated with reduced hours, early retirement, or job switching.
From an ethical standpoint, it is imperative that we recognize the value and importance of women’s health. Women are no longer solely relegated to traditional roles, as they now make up half of the workforce and contribute significantly to the country’s economic growth. In light of this reality, it is our responsibility to ensure that research prioritizes their needs and addresses the unique challenges they face.
As we move forward, it is crucial that we continue these conversations in the workplace, with families, elected officials, public health practitioners, and most importantly, among ourselves. Women’s health must be a taboo topic of the past; instead, it should be an ongoing discussion that informs policy decisions and shapes our collective approach to healthcare.
In conclusion, it is essential that we not only acknowledge the historical inequities in women’s health but also work towards addressing them. By prioritizing their inclusion in clinical trials, acknowledging the economic burden of menopausal symptoms, and recognizing the ethical imperative for change, we can create a healthier, happier, and more productive nation.
Source: https://www.forbes.com/sites/bernadettebodenalbala/2025/03/21/a-scientific-economic-and-ethical-reflection-on-womens-health-history/
